Chronic Liver Failure
8
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
Aerobic Capacity Muscle Strength and Health Related Quality of Life in Children With Chronic Liver Disease
Lactoferrin in Treatment of Fe Deficient Anemia In Cirrhosis
The Early Strength Training Program in Post-transplant Liver Cases
Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool
To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure